[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4062/biomolther.2013.113

VEGF-VEGFR Signals in Health and Disease

Shibuya, Masabumi (Jobu University, Institute of Physiology and Medicine)

Publication Information

Biomolecules & Therapeutics / v.22, no.1, 2014 , pp. 1-9 More about this Journal

Abstract

Vascular endothelial growth factor (VEGF)-VEGF receptor (VEGFR) system has been shown to play central roles not only in physiological angiogenesis, but also in pathological angiogenesis in diseases such as cancer. Based on these findings, a variety of anti-angiogenic drugs, including anti-VEGF antibodies and VEGFR/multi-receptor kinase inhibitors have been developed and approved for the clinical use. While the clinical efficacy of these drugs has been clearly demonstrated in cancer patients, they have not been shown to be effective in curing cancer, suggesting that further improvement in their design is necessary. Abnormal expression of an endogenous VEGF-inhibitor sFlt-1 has been shown to be involved in a variety of diseases, such as preeclampsia and aged macular degeneration. In addition, various factors modulating angiogenic processes have been recently isolated. Given this complexity then, extensive studies on the interrelationship between VEGF signals and other angiogenesis-regulatory systems will be important for developing future strategies to suppress diseases with an angiogenic component.

Keywords

VEGF; VEGF receptor; Angiogenic signals; Anti-Angiogenic therapy;

Citations & Related Records

Reference

1	Alitalo, K. and Carmeliet, P. (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219-227. DOI ScienceOn
2	Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., Townson, S., Wells, C., Little, M., Cummings, M. C., Hayward, N. K. and Kay, G. F. (2000) Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ. Res. 86, E29-35. DOI
3	Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Martovani, A. and Marme, D. (1996) Migration of human monocytes in response to vascular endothelilal growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
4	Beck, H., Raab, S., Copanaki, E., Heil, M., Scholz, A., Shibuya, M., Deller, T., Machein, M. and Plate, K. H. (2010) VEGFR-1 signaling regulates the homing of bone marrow derived cells in a mouse stroke model. J. Neuropathol. Exp. Neurol. 69,168-175. DOI
5	Bry, M., Kivela, R., Holopainen, T., Anisimov, A., Tammela, T., Soronen, J., Silvola, J., Saraste, A., Jeltsch, M., Korpisalo, P., Carmeliet, P., Lemstrom, K. B., Shibuya, M., Yla-Herttuala, S., Alhonen, L., Mervaala, E., Andersson, L. C., Knuuti, J. and Alitalo, K. (2010) Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122,1725-1733. DOI ScienceOn
6	De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N. and Williams, L. T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991 DOI
7	Carmellet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kleckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawlling, J., Moons, L., Collen, D., Risau, W. and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439. DOI ScienceOn
8	Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J. and Risau, W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J. Biol. Chem. 271, 17629-17634. DOI ScienceOn
9	Cohen, M. H., Gootenberg, J., Keegan, P. and Pazdur, R. (2007) FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. Oncologist 12, 713-718. DOI
10	Dhondt, J., Peeraer, E., Verheyen, A., Nuydens, R., Buysschaert, I., Poesen, K., Van Geyte, K., Beerens, M., Shibuya, M., Haigh, J. J., Meert, T., Carmeliet, P. and Lambrechts, D. (2011) Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons. FASEB J. 25, 1461-1473. DOI
11	Dias, S., Shmelkov, S. V., Lam, G. and Rafii S. (2002) VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 99, 2532-2540. DOI
12	Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M. and Alitalo, K. (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949. DOI
13	Dvorak, H. F. (2002) Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20, 4368-4380. DOI ScienceOn
14	Freitas, C., Larrivee, B. and Eichmann, A. (2008) Netrins and UNC5 receptors in angiogenesis. Angiogenesis 11, 23-29. DOI
15	Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442. DOI ScienceOn
16	Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611. DOI ScienceOn
17	Fong, G. H., Rossant, J., Gertsentein, M. and Breitman, M. L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70. DOI ScienceOn
18	Gilbert, J. S., Babcock, S. A. and Granger, J. P. (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble Fms-like tyrosine kinase-1 expression. Hypertension 50, 1142-1147. DOI
19	Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364. DOI ScienceOn
20	Heldin, C. H. and Westermark, B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316. DOI
21	Hida, K., Ohga, N., Akiyama, K., Maishi, N. and Hida, Y. (2013) Heterogeneity of tumor endothelial cells. Cancer Sci. Aug 12. doi: 10.1111/cas.12251. [Epub ahead of print] DOI
22	Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. and Shibuya, M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 95, 9349-9354. DOI ScienceOn
23	Kato, T., Ito, Y., Hosono, K., Suzsuki, T., Tamaki, H., Minamino, T., Kato, S., Sakagami, H., Shibuya, M. and Majima, M. (2011) Vascular endothelial growth factor receptor-1 signaling promotes liver repair through restoration of liver microvasculature after acetaminophen hepatotoxicity. Toxicol. Sci. 120, 218-229. DOI
24	Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M. and Shibuya, M. (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung specific metastasis. Cancer Cell 2, 289-300. DOI ScienceOn
25	Huveldt, D., Lewis-Tuffin, L. J., Carlson, B. L., Schroeder, M. A., Rodriguez, F., Giannini, C., Galanis, E., Sarkaria, J. N. and Anastasiadis, P. Z. (2013) Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion. PLoS One. 8, e56505. DOI
26	Jin, J., Sison, K., Li, C., Tian, R., Wnuk, M., Sung, H. K., Jeansson, M., Zhang, C., Tucholska, M., Jones, N., Kerjaschki, D., Shibuya, M., Fantus, I. G., Nagy, A., Gerber, H. P., Ferrara, N., Pawson, T., and Quaggin, S. E. (2012) Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151, 384-399. DOI
27	Kerber, M., Reiss, Y., Wickersheim, A., Jugold, M., Kiessling, F., Heil, M., Tchaikovski, V., Waltenberger, J., Shibuya, M., Plate, K.H. and Machein, M.R. (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. 68, 7342-7351. DOI
28	Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H. and Ferrara, N. (1996) Identification of vascular endothelial growth factor determinanats for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271, 5638-5646. DOI
29	Kim, M., Park, H. J., Seol, J. W., Jang, J. Y., Cho, Y. S., Kim, K. R., Choi, Y., Lydon, J. P., Demayo, F. J., Shibuya, M., Ferrara, N., Sung, H. K., Nagy, A., Alitalo, K. and Koh, G. Y. (2013) VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodeling during pregnancy. EMBO Mol. Med. 5, 1415-1430. DOI
30	Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844. DOI ScienceOn
31	Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O. and Taketani, Y. (2003) Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J. Clin. Endocrinol. Metab. 88, 2348-2351. DOI ScienceOn
32	Kumasawa, K., Ikawa, M., Kidoya, H., Hasuwa, H., Saito-Fujita, T., Morioka, Y., Takakura, N., Kimura, T. and Okabe, M. (2011) Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc. Natl. Acad. Sci. U.S.A. 108, 1451-1455. DOI
33	Laurent, J., Hull, E. F., Touvrey, C., Kuonen, F., Lan, Q., Lorusso, G., Doucey, M. A., Ciarloni, L., Imaizumi, N., Alghisi, G.C., Fagiani, E., Zaman, K., Stupp, R., Shibuya, M., Delaloye, J. F., Christofori, G. and Ruegg, C. (2011) Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors. Cancer Res. 71, 3781-3791. DOI
34	Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309. DOI
35	Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., Epstein, F. H., Sukhatme, V. P. and Karumanchi, S. A. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658. DOI
36	Levine, R. J., Maynard, S. E., Qian, C., Lim, K. H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., Sibai, B. M., Sukhatme, V. P. and Karumanchi, S. A. (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683. DOI ScienceOn
37	Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P., Wang, L., Wikner, C., Qi, J. H., Wernstedt, C., Wu, J., Bruheim, S., Mugishima, H., Mukhopadhyay, D., Spurkland, A. and Claesson-Welsh, L. (2005) VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 24, 2342-2353. DOI ScienceOn
38	Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y. and Shibuya, M. (2006) Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocyte/macrophages. Blood 108, 1849-1856. DOI
39	Mezquita, J., Mezquita, B., Pau, M. and Mezquita, C. (2003) Down-regulation of Flt-1 gene expression by the proteasome inhibitor MG262. J. Cell. Biochem. 89, 1138-1147. DOI
40	Minami, T., Horiuchi, K., Miura, M., Abid, M. R., Takabe, W., Noguchi, N., Kohro, T., Ge, X., Aburatani, H., Hamakubo, T., Kodama, T. and Aird, W. C. (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J. Biol. Chem. 279, 50537-50554. DOI ScienceOn
41	Niida, S., Kondo, T., Hiratsuka, S., Hayashi, S. I., Amizuka, N., Noda, T., Ikeda, K. and Shibuya, M. (2005) VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 102, 14016-14021. DOI
42	Muramatsu, M., Yamamoto, S., Osawa, T. and Shibuya, M. (2010) Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. Cancer Res. 70, 8211-8221. DOI
43	Nagamatsu, T., Fujii, T., Kusumi, M., Zou, L., Yamashita, T., Osuga, Y., Momoeda, M., Kozuma, S. and Taketani, Y. (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145, 4838-4845. DOI ScienceOn
44	Osawa, T., Tsuchida, R., Muramatsu, M., Shimamura, T., Wang, F., Suehiro, J. I., Kanki, Y., Wada, Y., Yuasa, Y., Aburatani, H., Miyano, S., Minami, T., Kodama, T. and Shibuya, M. (2013) Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor associated macrophages. Cancer Res. 73, 3019-3028. DOI
45	Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Lin, H. C., Yancopoulos, G. D. and Thurston, G. (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 444, 1032-1037. DOI
46	Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674. DOI ScienceOn
47	Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Hellings, P., Gorselink, M., Heymans, S., Theilmeier, G., Dewerchin, M., Laudenbach, V., Vermylen, P., Raat, H., Acker, T., Vleminckx, V., Van Den Bosch, L., Cashman, N., Fujisawa, H., Drost, M. R., Sciot, R., Bruyninckx, F., Hicklin, D. J., Ince, C., Gressens, P., Lupu, F., Plate, K. H., Robberecht, W., Herbert, J. M., Collen, D. and Carmeliet, P. (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28, 131-138. DOI ScienceOn
48	Sase, H., Watabe, T., Kawasaki, K., Miyazono, K. and Miyazawa, K. (2009) VEGFR2-PLCgamma1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells. J. Cell Sci. 122, 3303-3311. DOI
49	Pritchard-Jones, R. O., Dunn, D. B., Qiu, Y., Varey, A. H., Orlando, A., Rigby, H., Harper, S. J. and Bates, D. O. (2007) Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br. J. Cancer 97, 223-230. DOI ScienceOn
50	Sallinen, H., Anttila, M., Grohn, O., Koponen, J., Hamalainen, K., Kholova, I., Kosma, V.M., Heinonen, S., Alitalo, K. and Yla-Herttuala S. (2011) Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice. Cancer Gene Ther. 18, 100-109. DOI
51	Sato, T., Amano, H., Ito, Y., Eshima, K., Minamino, T., Ae, T., Katada, C., Ohno, T., Hosono, K., Suzuki, T., Shibuya, M., Koizumi, W. and Majima M. (2013) NSAID, aspirin delays gastric ulcer healing with reduced accumulation of CXCR4+VEGFR1+ cells to the ulcer granulation tissues. Biomed Pharmacother. 67, 607-613. DOI
52	Sato, Y. (2013) The vasohibin family: a novel family for angiogenesis regulation. J. Biochem. 153, 5-11. DOI
53	Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H. and Sato, M. (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-524.
54	Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, T. and Shibuya, M. (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor (PlGF), which is related to vascular endothelial growth factor (VEGF). Cell Growth Diff. 7, 213-221.
55	Schwartz, J. D., Rowinsky, E. K., Youssoufian, H., Pytowski, B. and Wu, Y. (2010) Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1). Cancer 116,1027-1032. DOI ScienceOn
56	Shibuya, M. (2006) Vascular endothelial growth factor receptor-1 (VEGFR1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 9, 225-230 DOI
57	Shibuya, M. and Claesson-Welsh, L. (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell. Res. 312, 549-560. DOI ScienceOn
58	Shibuya, M. (2011) Involvement of Flt-1 (VEGFR-1) in cancer and preeclampsia. Proc. Jpn. Acad Ser. B. Phys. Biol. Sci. 87, 167-178. DOI
59	Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996) Requisite role of Angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180. DOI ScienceOn
60	Takahashi, T., Ueno, H. and Shibuya, M. (1999) VEGF activates Protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 2221-2230. DOI ScienceOn
61	Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., Hemphill, L., Rigby, A. C., Khedkar, S., Lindner, T. H., Mallmann, P., Stepan, H., Karumanchi, S. A. and Benzing, T. (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940-950. DOI
62	Takahashi, T., Yamaguchi, S., Chida, K. and Shibuya, M. (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC- ${\gamma}$ and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778. DOI ScienceOn
63	Verheyen, A., Peeraer, E., Nuydens, R., Dhondt, J., Poesen, K., Pintelon, I., Daniels, A., Timmermans, J. P., Meert, T., Carmeliet, P. and Lambrechts, D. (2012) Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy. Brain 135, 2629-2641. DOI
64	Tanaka, K., Yamaguchi, S., Sawano, A. and Shibuya, M. (1997) Characterization of the extracellular domain in the vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). Jpn. J. Cancer Res. 88, 867-876. DOI
65	Wang, H. U., Chen, Z. F. and Anderson, D. J. (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753. DOI ScienceOn
66	Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A. and Weinberg, R. A. (2003) Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219-231. DOI
67	Wittko, I. M., Schanzer, A., Kuzmichev, A., Schneider, F. T., Shibuya, M., Raab, S. and Plate, K. H. (2009) VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo. J. Neurosci. 29, 8704-8714,. DOI ScienceOn
68	Yan, M., Callahan, C. A., Beyer, J. C., Allamneni, K. P., Zhang, G., Ridgway, J. B., Niessen, K. and Plowman, G. D. (2010) Chronic DLL4 blockade induces vascular neoplasms. Nature 463, E6-7. DOI
69	Xiong, Y., Huo, Y., Chen, C., Zeng, H., Lu, X., Wei, C., Ruan, C., Zhang, X., Hu, Z., Shibuya, M. and Luo, J. (2009) Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways. J. Biol. Chem. 284, 23217-23224. DOI
70	Yamauchi, M., Imajoh-Ohmi, S. and Shibuya, M. (2007) Novel anti-angiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci. 98, 1491-1497. DOI
71	Young, B. C., Levine, R. J. and Karumanchi, S. A. (2010) Pathogenesis of preeclampsia. Annu. Rev. Pathol. 5, 173-192. DOI ScienceOn
72	Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., Zhu, Z., Hicklin, D., Wu, Y., Port, J. L., Altorki, N., Port, E. R., Ruggero, D., Shmelkov, S. V., Jensen, K. K., Rafii, S. and Lyden, D. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827. DOI ScienceOn
73	Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N. and Shibuya, M. (2005) Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 102, 1076-1081. DOI ScienceOn
74	Kendall, R. L. and Thomas, K. A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10705-10709. DOI ScienceOn
75	Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R. J., Richter, E., Sakurai, E., Newcomb, M. T., Kleinman, M. E., Caldwell, R. B., Lin, Q., Ogura, Y., Orecchia, A., Samuelson, D. A., Agnew, D. W., St Leger, J., Green, W. R., Mahasreshti, P. J., Curiel, D. T., Kwan, D., Marsh, H., Ikeda S, Leiper, L. J., Collinson, J. M., Bogdanovich, S., Khurana, T. S., Shibuya, M., Baldwin, M. E., Ferrara, N., Gerber, H. P., De Falco, S., Witta, J., Baffi, J. Z., Raisler, B. J. and Ambati, J. (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443, 993-997. DOI ScienceOn
76	Foidart, J. M., Schaaps, J. P., Chantraine, F., Munaut, C. and Lorquet, S. (2009) Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J. Reprod. Immunol. 82, 106-111. DOI
77	Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., Ferrara, N., Fyfe, G., Rogers, B., Ross, R. and Kabbinavar, F. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335-2342. DOI ScienceOn
78	Luo, L., Uehara, H., Zhang, X., Das, S. K., Olsen, T., Holt, D., Simonis, J. M., Jackman, K., Singh, N., Miya, T. R., Huang, W., Ahmed, F., Bastos-Carvalho, A., Le, Y. Z., Mamalis, C., Chiodo, V. A., Hauswirth, W. W., Baffi, J., Lacal, P. M., Orecchia, A., Ferrara, N., Gao, G., Young-Hee, K., Fu, Y., Owen, L., Albuquerque, R., Baehr, W., Thomas, K., Li, D. Y., Chalam, K. V., Shibuya, M., Grisanti, S., Wilson, D. J., Ambati, J. and Ambati, B. K. (2013) Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife 2:e00324.
79	Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Schuh, A. C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66. DOI ScienceOn
80	Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Vinals, F., Inoue, M., Bergers, G., Hanahan, D. and Casanovas, O. (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 15, 220-231. DOI ScienceOn
81	Tammela, T., Zarkada, G., Wallgard, E., Murtomaki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellstrom, M., Schomber, T., Peltonen, R., Freitas, C., Duarte, A., Isoniemi, H., Laakkonen, P., Christofori, G., Yla-Herttuala, S., Shibuya, M., Pytowski, B., Eichmann, A., Betsholtz, C. and Alitalo, K. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656-660. DOI

Reference

7	Shalini Gross. (2017) Journal of Cerebral Blood Flow & Metabolism Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation / 37 (7) , 2471
6	Jun Xie. (2015) Acta Pharmaceutica Sinica B The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line / 5 (6) , 554
3	Avner Adini. (2017) Angiogenesis A novel strategy to enhance angiogenesis in vivo using the small VEGF-binding peptide PR1P / 20 (3) , 399
5	Gokhan Adas. (2016) Langenbeck's Archives of Surgery Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection / 401 (5) , 725
	Maria Eduarda Lopes Baitello. (2016) Canadian Journal of Gastroenterology and Hepatology VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular Carcinoma / 2016 , 1
4	Chandran S. Abhinand. (2016) Journal of Cell Communication and Signaling VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis / 10 (4) , 347
6	Konstantin Schwarz. (2016) Future Cardiology A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS / 12 (6) , 617
6	Megan Kim. (2015) Survey of Ophthalmology Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review / 60 (6) , 524
1	GUANGYAN LI. (2016) Molecular Medicine Reports MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C / 13 (1) , 572
6	Nan Che. (2015) Immunobiology Investigation on association between five common polymorphisms in vascular endothelial growth factor and prototypes of autoimmune diseases / 220 (6) , 722
2	Tianzhi Yang. (2017) The AAPS Journal Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer / 19 (2) , 475
1	Farid Ouchani. (2015) Investigational New Drugs Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent / 33 (1) , 75
5	Jun-Min Yu. (2015) Molecular Medicine Reports Astragalosides promote angiogenesis via vascular endothelial growth factor and basic fibroblast growth factor in a rat model of myocardial infarction / 12 (5) , 6718
3	Lei Zhou. (2016) Tumor Biology Differential function and regulation of orphan nuclear receptor TR3 isoforms in endothelial cells / 37 (3) , 3307
	Mahdy Ranjbar. (2016) Cytokine Ranibizumab interacts with the VEGF-A/VEGFR-2 signaling pathway in human RPE cells at different levels / 83 , 210
3	Soo Geun Joe. (2015) PLOS ONE Anti-Angiogenic Effect of Metformin in Mouse Oxygen-Induced Retinopathy Is Mediated by Reducing Levels of the Vascular Endothelial Growth Factor Receptor Flk-1 / 10 (3) , e0119708
	Yunlong Yang. (2016) Nature Communications Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism / 7 , 12680
1	Jose Luis Castañeda-Cabral. (2017) Journal of Molecular Neuroscience Glutamate Neonatal Excitotoxicity Modifies VEGF-A, VEGF-B, VEGFR-1 and VEGFR-2 Protein Expression Profiles During Postnatal Development of the Cerebral Cortex and Hippocampus of Male Rats / 63 (1) , 17
15	Lei Wang. (2017) Journal of Medicinal Chemistry Identification of Peptidic Antagonists of Vascular Endothelial Growth Factor Receptor 1 by Scanning the Binding Epitopes of Its Ligands / 60 (15) , 6598
10	Lei Wang. (2014) Molecules Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists / 19 (10) , 15391
5	Hyun-Kyung Kim. (2017) Journal of Cellular Biochemistry A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization / 118 (5) , 1132
1	Ning Liang. (2017) International Journal of Oncology Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways / 51 (1) , 213
	Maryam Saberi-Karimian. (2017) Critical Reviews in Food Science and Nutrition Vascular endothelial growth factor: An important molecular target of curcumin / , 1
5	JIE SHAO. (2016) Molecular Medicine Reports Transfection of chondromodulin I into human breast cancer cells and its effect on the inhibition of cancer cell growth / 13 (5) , 4303
6	Yinan Wang. (2015) PLOS ONE KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells / 10 (6) , e0130341
	Divyashree Ravishankar. (2015) European Journal of Medicinal Chemistry Exploring quercetin and luteolin derivatives as antiangiogenic agents / 97 , 259
15	Yin Zhang. (2016) Proceedings of the National Academy of Sciences Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy / 113 (15) , 4158
4	Yi-Yong Baek. (2015) Biochemical and Biophysical Research Communications The tetrapeptide Arg-Leu-Tyr-Glu inhibits VEGF-induced angiogenesis / 463 (4) , 532
	IvÃ¡n RodrÃguez. (2014) Frontiers in Pharmacology Physiological mechanisms of vascular response induced by shear stress and effect of exercise in systemic and placental circulation / 5
3	Aniruddha Agarwal. (2016) Pharmacogenomics The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy / 17 (3) , 309
11	Sandra Rother. (2017) ACS Applied Materials & Interfaces Sulfated Hyaluronan Alters Endothelial Cell Activation in Vitro by Controlling the Biological Activity of the Angiogenic Factors Vascular Endothelial Growth Factor-A and Tissue Inhibitor of Metalloproteinase-3 / 9 (11) , 9539
7	Martina Moritz. (2017) Journal of Tissue Engineering and Regenerative Medicine VEGF released from a fibrin biomatrix increases VEGFR-2 expression and improves early outcome after ischaemia-reperfusion injury / 11 (7) , 2153
	Federico Corti. (2017) Pharmacological Research Modulation of VEGF receptor 2 signaling by protein phosphatases / 115 , 107
1	David Della-Morte. (2015) Pharmacogenomics Impact ofVEGFgene polymorphisms in elderly cancer patients: clinical outcome and toxicity / 16 (1) , 61
1	Nandita S. Raikwar. (2016) Experimental Cell Research Ectodomain cleavage of FLT1 regulates receptor activation and function and is not required for its downstream intracellular cleavage / 344 (1) , 103
19	Mei-Kuang Chen. (2015) FEBS Journal Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases / 282 (19) , 3693
	C.C. Drewes. (2015) Toxicon Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells / 101 , 1
	Yin Zhang. (2017) Proceedings of the National Academy of Sciences Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy / , 201705066
6	Shuang Li. (2015) Cancer Biology & Therapy Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer / 16 (6) , 866
4	R. V. Deev. (2015) Kardiologiya i serdechno-sosudistaya khirurgiya Long-term results of pl-VEGF165 intramuscular gene transfer in patients with atherosclerotic chronic lower limb ischemia / 8 (4) , 43
2	Sandra Markovic-Mueller. (2017) Structure Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A / 25 (2) , 341
	Jin Zhang. (2016) European Journal of Medicinal Chemistry Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs / 108 , 495
00219541	(2018) Journal of Cellular Physiology Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling / (00219541)
8	(2018) Molecules Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway / 23 (8) , 2047
10	(2014) Arteriosclerosis, Thrombosis, and Vascular Biology Nucleoside Diphosphate Kinase B Regulates Angiogenesis Through Modulation of Vascular Endothelial Growth Factor Receptor Type 2 and Endothelial Adherens Junction Proteins / 34 (10) , 2292
2	(2017) Circulation Research b Modulates Endothelial VEGFR1–STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease / 120 (2) , 282
12	(2017) JDDG: Journal der Deutschen Dermatologischen Gesellschaft Infantile hemangioma: pathogenesis and mechanisms of action of propranolol / 15 (12) , 1185
12	(2017) JDDG: Journal der Deutschen Dermatologischen Gesellschaft Das infantile Hämangiom: Pathogenese und Wirkmechanismus von Propranolol / 15 (12) , 1185
1663-9812	(2018) Frontiers in Pharmacology Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling / 9 (1663-9812)
12	(2018) International Journal of Molecular Sciences Vascular Endothelial Growth Factor, from Basic Research to Clinical Applications / 19 (12) , 3750
2	(2018) The Journal of Experimental Medicine Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning / 215 (2) , 611
2	(2018) American Journal of Physiology-Cell Physiology VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis / 315 (2) , C214
3	(2018) Zygote The urokinase plasminogen activator system components are regulated by vascular endothelial growth factor D in bovine oviduct / 26 (3) , 242
5	(2014) Oncology letters Inhibitory effect of carboplatin in combination with bevacizumab on human retinoblastoma in an <I>in vitro</I> and <I>in vivo</I> model / 14 (5) , 5326
10665099	(2018) STEM CELLS A Subset of Paracrine Factors as Efficient Biomarkers for Predicting Vascular Regenerative Efficacy of Mesenchymal Stromal/Stem Cells / (10665099)
2296-4185	(2018) Frontiers in Bioengineering and Biotechnology Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification / 6 (2296-4185)
3	(2018) Angiogenesis Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling / 21 (3) , 533
5	(2014) Bioscience reports The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis / 35 (5) , e00253
3	(2014) The Journal of pharmacology and experimental therapeutics Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice / 354 (3) , 269
80	(2014) Journal of evidence based medicine and healthcare VASCULAR ENDOTHELIAL GROWTH FACTOR IN HEALTH AND DISEASE: A REVIEW / 3 (80) , 4363
9	(2014) Journal of medicinal chemistry Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T / 61 (9) , 4135
3	(2014) Bioconjugate chemistry Targeting Fluorescent Nanodiamonds to Vascular Endothelial Growth Factor Receptors in Tumor / 30 (3) , 604
5	(2014) Molecular medicine reports Umbilical cord blood-derived Helios-positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA-VEGFR2 pathway / 19 (5) , 4195
10	(2014) Experimental & molecular medicine : EMM 6′-Sialylgalactose inhibits vascular endothelial growth factor receptor 2-mediated angiogenesis / 51 (10) , 1
7	(2014) Molecular biotechnology Human Recombinant VEGFR2D4 Biochemical Characterization to Investigate Novel Anti-VEGFR2D4 Antibodies for Allosteric Targeting of VEGFR2 / 61 (7) , 513
4	(2019) Molecular biology reports Anti-angiogenic activity of Gracilaria coronopifolia J.G. Agardh extract by lowering the levels of trace metals (iron, zinc and copper) in duck chorioallantoic membrane and in vitro activation of AMP- / 46 (4) , 4151
8	(2014) Cells Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics / 8 (8) , 863
11	(2014) Molecular biotechnology Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7 / 61 (11) , 860
1	(2014) Stem cell research & therapy Autograft microskin combined with adipose-derived stem cell enhances wound healing in a full-thickness skin defect mouse model / 10 (1) , 279
12	(2014) Kidney international reports Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD / 4 (12) , 1735
None	(2014) Current enzyme inhibition Antiangiogenesis Potential of Alpinumisoflavone as an Inhibitor of Matrix Metalloproteinase-9 (MMP-9) and Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) / 16 (None) , 159
12	(2014) Current pharmaceutical design Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases / 26 (12) , 1263
5	(2014) Journal of clinical medicine Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction / 9 (5) , 1277
18	(2014) Molecules Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways / 25 (18) , 4279
12	(2014) Cancers Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment / 12 (12) , 3744
3	(2021) Biomolecules Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data Analysis / 11 (3) , 403
3	(2014) Biomedicines Angiogenesis Is Differentially Modulated by Platelet-Derived Products / 9 (3) , 251
no.pb	(2014) International immunopharmacology Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients / 101 (no.pb) , 108257
None	(2014) Microvascular research Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells / 140 (None) , 104305